87S.F - Roivant Sciences Ltd.

Frankfurt - Frankfurt Delayed price. Currency in EUR
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
Total revenue
43,127
55,286
23,795
Cost of revenue
9,412
8,966
2,057
Gross profit
33,715
46,320
21,738
Operating expenses
Research development
528,435
483,035
236,626
Selling general and administrative
613,969
775,033
259,878
Total operating expenses
1,142,404
1,258,068
496,504
Operating income or loss
-1,108,689
-1,211,748
-474,766
Interest expense
20,868
7,041
2,809
Total other income/expenses net
-225,607
288,001
-422,390
Income before tax
-1,337,094
-923,747
-898,547
Income tax expense
8,820
369
1,686
Income from continuing operations
-1,345,914
-924,116
-900,233
Net income
-1,245,475
-845,262
-809,234
Net income available to common shareholders
-1,245,475
-845,262
-809,234
Basic EPS
-
-1.26
-1.18
Diluted EPS
-
-1.26
-1.18
Basic average shares
-
669,753
684,789
Diluted average shares
-
669,753
684,789
EBITDA
-
-1,211,748
-895,738